申请人:BAYER PHARMA AKTIENGESELLSCHAFT
公开号:US20150080434A1
公开(公告)日:2015-03-19
A compound of formula Ia:
The present invention relates to novel indazolyl derivatives, to pharmaceutical compositions comprising such derivatives, to processes for preparing such novel derivatives and to the use of such derivatives as medicaments
一种式Ia的化合物:本发明涉及新型吲唑基衍生物,包括这种衍生物的制药组合物,制备这种新型衍生物的方法以及将这种衍生物用作药物的用途。